Finance

Beta
Lists
PAR:NSE
Par Drugs and Chemicals Ltd
₹94.94
-1.51%
(-1.46) 1D
Jun 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for PAR...
Open
₹93.30
High
₹96.25
Low
₹93.30
Mkt. cap
1.17B
Avg. vol.
13.06K
Volume
7.99K
P/E ratio
8.91
52-wk high
₹122.43
52-wk low
₹78.05
EPS
₹10.65
No. of employees
121
Open
₹93.30
High
₹96.25
Low
₹93.30
Mkt. cap
1.17B
Avg. vol.
13.06K
Volume
7.99K
P/E ratio
8.91
52-wk high
₹122.43
52-wk low
₹78.05
EPS
₹10.65
No. of employees
121
News stories
From sources across the web
About Par Drugs and Chemicals Ltd
CEO-
Employees121
Founded1982
Headquarters-
SectorPharmaceutical industry
Websitepardrugs.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
260.46M
286.59M
293.40M
196.11M
Cost of goods sold
113.36M
107.24M
123.94M
89.08M
Cost of revenue
113.36M
107.24M
123.94M
89.08M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.20M
13.55M
14.10M
19.35M
Operating expense
120.54M
128.10M
118.14M
101.88M
Total operating expenses
233.89M
235.34M
242.08M
190.96M
Operating income
26.57M
51.25M
51.31M
5.14M
Other non operating income
18.37M
4.80M
13.26M
3.58M
EBT including unusual items
44.78M
55.50M
64.42M
8.32M
EBT excluding unusual items
44.78M
55.50M
64.42M
8.32M
Income tax expense
11.50M
14.21M
16.45M
-221.00K
Effective tax rate
25.68%
25.60%
25.53%
-2.66%
Other operating expenses
97.30M
105.14M
94.73M
73.25M
Net income
33.28M
41.30M
47.97M
8.54M
Net profit margin
12.78%
14.41%
16.35%
4.35%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-163.00K
-549.00K
-148.00K
-414.00K
Net interest expenses
-163.00K
-549.00K
-148.00K
-414.00K
Depreciation and amortization charges
9.04M
9.41M
9.31M
9.28M
EBITDA
35.69M
60.47M
60.43M
14.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer